Nitrosamine Impurities; What’s the Impact on IMPs
N-nitrosamines are a regulatory and industry hot topic and whilst the focus has been on marketed products rather than development portfolios, there is an impact on investigational medicinal product development and manufacture. This webinar, led by Paul Cummings, will discuss nitrosamine impurities including key considerations when developing an IMP, the risks of delaying a formal risk assessment and more.
How NSF Can Help You
Get in touch to find out how we can help you and your business thrive.
What’s New with NSF
2024 GFSI Conference - Meeting the Needs of our Evolving World
March 20, 2024NSF is proud to announce our sponsorship of the GFSI Conference, an annual event dedicated to advancing food safety and consumer trust.
Read the Story
Dwayne “The Rock” Johnson’s ZOA+ Powder Earns NSF Certified for Sport® Certification
March 4, 2024New Pre-Workout Powder Joins Elite Group of NSF Certified For Sport® Dietary Supplements.
Read the Story
February 2024 Pharma News Update
February 15, 2024The February 2024 update looks at the FDA’s guidance on conducting remote regulatory assessments and more.
Read the Story